A Study in People With Overweight or Obesity to Test How BI 1820237, BI 456906, or a Combination of Both Affects Brain Activity

NCT06352424 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: BI 456906
DRUG: BI 1820237
DRUG: Placebo for BI 1820237
DRUG: Placebo for BI 456906

Sponsor

Boehringer Ingelheim